Understanding the BALANCE Model for GLP-1 Medications in Medicare and Medicaid

• by Meredith Freed, Juliette Cubanski, Elizabeth Williams

• April 22, 2026

GLP-1 Analysis: Riding the Wave of Peptide Innovation

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.

• by Amanda M. Guiraldelli, Piotr Alvarez, Koen Sandra

• January 26, 2026

• 17 min

Cost-Effectiveness Analysis of a Comprehensive Obesity Prevention Program in Primary Schools in China

• by Shiyu Yan, Shuang Zhou, Xiru Guo, Jinlang Lyu, Hui Wang, Hai Fang, Hai-Jun Wang

• November 24, 2025

Efficacy of Long-Term Physical Activity Interventions for Preventing Obesity-Related Cancers: Insights from a Simulated Target Trial in a Prospective US Cohort

• by Valeria Elahy, Yu-Han Chiu, Alpa V. Patel, Erika Rees-Punia, Marjorie L. McCullough, Anita R. Peoples, Ying Wang

• October 27, 2025